新剂型二甲双胍的缓释制剂(sustained release preparation)是利用包衣、加入阻滞剂等手段来延缓或控制药物释放速度,以达到调整药物作用时间、减轻毒副作用等目的。
基于122个网页-相关网页
... 第一节 概述 • 缓释、控释制剂的定义 凡是能够延缓药物释放的一类制剂，称为延缓释放制剂（ sustained release preparation,SRP ） , 即缓释制剂。
基于4个网页-相关网页
... 第一节 概述 • 缓释、控释制剂的定义 凡是能够延缓药物释放的一类制剂，称为延缓释放制剂（ sustained release preparation,SRP ） , 即缓释制剂。
基于2个网页-相关网页
Nifedipine Sustained Release Preparation 硝苯地平缓释片
Sustained-release preparation 缓释制剂
oral sustained-release preparation 口服控释制剂
Guchi sustained release preparation 固齿缓释剂
compound sustained-release preparation 复方缓释制剂
Shuanghuangbu sustained-release preparation 双黄补药条
chinese herbal sustained-release preparation 中药缓释药条
These results suggested that this granulation method was useful in preparing a sustained release preparation of water soluble medicine.
本制粒法可用于水溶性药物控释制剂的制备。
The invention relates to a sustained release preparation of a novel prescription for treating hypertension and the preparing method thereof.
本发明涉及一种用于治疗高血压的新组方的缓释制剂及制备方法。
Conclusions Dihydropyridine calcium antagonist is promising, and the sustained release preparation or controlled release preparation would be more and more frequently used.
结论钙拮抗药应用趋势是二氢吡啶类药物前景看好，缓、控释制剂应用将更普遍。
应用推荐